Mastrangelo, A., Armitage, E. G. , García, A. and Barbas, C. (2014) Metabolomics as a tool for drug discovery and personalised medicine. A review. Current Topics in Medicinal Chemistry, 14(23), pp. 2627-2636. (doi: 10.2174/1568026614666141215124956) (PMID:25515755)
Full text not currently available from Enlighten.
Abstract
Studying the effects of drugs on the metabolome constitutes a huge part of the metabolomics discipline. Whether the approach is associated with drug discovery (altered pathways due to the disease that provide future targets and information into the mechanism of action or resistance, etc.) or pharmacometabolomics (studying the outcome of treatment), there have been many aspiring published articles in this area. With specific experimental design, including fingerprinting analysis with different analytical platforms in a non-targeted way, the approach is advancing towards the discovery of markers for the implication of personalised medicine, while also providing information that could help to improve the efficacy and reduce the side effects associated with a treatment. In this review, the evolution of pharmacometabolomics from other areas of drug efficacy metabolomics studies is explored.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Armitage, Dr Emily Grace |
Authors: | Mastrangelo, A., Armitage, E. G., García, A., and Barbas, C. |
College/School: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity |
Journal Name: | Current Topics in Medicinal Chemistry |
Publisher: | Bentham Science Publishers |
ISSN: | 1568-0266 |
ISSN (Online): | 1873-4294 |
University Staff: Request a correction | Enlighten Editors: Update this record